Skip to Content
Merck
CN

13635

1-Z-4-Piperidone

purum, ≥95.0% (HPLC)

Synonym(s):

1-(Benzyloxycarbonyl)-4-piperidinone, 1-Cbz-4-Piperidone, Benzyl 4-oxo-1-piperidinecarboxylate

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):
C13H15NO3
CAS Number:
Molecular Weight:
233.26
Beilstein/REAXYS Number:
1533716
PubChem Substance ID:
UNSPSC Code:
12352100
MDL number:
Assay:
≥95.0% (HPLC)
Form:
solid
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


grade

purum

Quality Level

assay

≥95.0% (HPLC)

form

solid

refractive index

n20/D 1.542

bp

114-140 °C/0.25 mmHg (lit.)

density

1.172 g/mL at 25 °C (lit.)

SMILES string

O=C1CCN(CC1)C(=O)OCc2ccccc2

InChI

1S/C13H15NO3/c15-12-6-8-14(9-7-12)13(16)17-10-11-4-2-1-3-5-11/h1-5H,6-10H2

InChI key

VZOVOHRDLOYBJX-UHFFFAOYSA-N

General description

1-Z-4-Piperidone is the starting material in biheteroaromatic diphosphine oxides-catalyzed stereoselective direct aldol condensation reactions.


Still not finding the right product?

Explore all of our products under 1-Z-4-Piperidone


pictograms

Exclamation mark

signalword

Warning

hcodes

Hazard Classifications

Acute Tox. 4 Oral - Aquatic Chronic 3

Storage Class

10 - Combustible liquids

wgk

WGK 3

flash_point_f

235.4 °F - closed cup

flash_point_c

113 °C - closed cup

ppe

Eyeshields, Gloves

Regulatory Information

危险化学品

This item has



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Biheteroaromatic diphosphine oxides-catalyzed stereoselective direct aldol reactions.
Rossi S, et al.
Tetrahedron, 67(1), 158-166 (2011)
Svetlana Paskaš et al.
Molecular carcinogenesis, 58(8), 1362-1375 (2019-04-19)
The main focus of this study is exploring the effect and mechanism of two HIV-protease inhibitors: Ritonavir and Ritonavir-nitric oxide (Ritonavir-NO) on in vitro growth of melanoma cell lines. NO modification significantly improved the antitumor potential of Ritonavir, as the



Global Trade Item Number

SKUGTIN
13635-2.5KG-R04061833595060
13635-1KG-R04061826714393
13635-6X1KG-R04061833684740
13635-6X2.5KG-R04061833595077